Researchers have unveiled two major biomedical engineering advances: a medium-scale bioreactor that produces 40 million human macrophages weekly from stem cells, and an AI-powered microfluidic ...

Researchers at City of Hope, a cancer research and treatment organization, and the University of California, Berkeley, have created a novel microfluidic platform that can assess women's breast cancer ...

In a recent review article published in the journal Microsystems & Nanoengineering, researchers explored the advancements in microfluidic technologies for monitoring the electromechanical activity of ...

Researchers have introduced groundbreaking tools—from a microfluidic platform measuring breast cell 'mechanical age' to AI-driven mammogram risk assessments—that could transform breast cancer ...

(Nanowerk News) In a recently published study in Analyst ("From mouth to gut: microfluidic in vitro simulation of human gastro-intestinal digestion and intestinal permeability"), INL researchers ...

Stephen Quake, a bioengineer and applied physicist at Stanford University, has always been interested in the interface between physics and biology. During his work at the California Institute of ...

AI has designed candidate drugs for antibiotic-resistant infections and genetic diseases. But efforts to incorporate AI into the design of lipid nanoparticles (LNPs), the revolutionary delivery ...

(Nanowerk Spotlight) Microfluidics, the technology of precisely controlling fluids at the submillimeter scale, has long held the promise of revolutionizing biological research and medical diagnostics.

The challenge is that the tumor immune microenvironment is not a static backdrop but a constantly shifting ecosystem shaped by cancer cells, immune cells, stromal cells, cytokines, and physical ...

Dielectrophoresis (DEP) is an electrokinetic phenomenon that induces the motion of polarisable particles in a non-uniform electric field. This method, utilised within microfluidic devices, has evolved ...

NEWARK, DE / ACCESS Newswire / March 23, 2026 / The global microfluidic organ-on-chip drug testing market is entering a rapid growth phase as pharmaceutical and biotechnology companies transition from ...